Hypromellose
As of the edition of 20 October 2026, Hypromellose is a drug: marketed, first approved in 1969 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1999
- Kind
- Unknown
- Brand name
- Alcon Tears
- First approved
- 31 December 1969 (CA)
- Approvals on record
- 8 in 4 regions
- Holder of the most recent approval
- Alcon; 2 holders in all
- Registered trials
- 17, 1 stopped early
- Disease areas
- Eye; Bones, joints and muscles; Immune system; Mouth and teeth; Skin and connective tissue; Infections
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 7 | 2 | 0 | 0 |
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 2 | 4 | 2 | 0 | 1 |
| Phase 3 | 1 | 1 | 0 | 0 |
| Phase 4 | 3 | 3 | 0 | 0 |
| All trials | 17 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Alcon | Applicant | 1969 to now |